You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for Patent: 10,471,067

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,471,067 protect, and when does it expire?

Patent 10,471,067 protects ANJESO and is included in one NDA.

This patent has eighteen patent family members in nine countries.

Summary for Patent: 10,471,067

Title:	Nanoparticulate meloxicam formulations
Abstract:	The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Inventor(s):	Cooper; Eugene R. (Berwyn, PA), Ryde; Tuula (Malvern, PA), Pruitt; John (Suwanee, GA), Kline; Laura (Harleysville, PA)
Assignee:	Recro Pharma, Inc. (Malvern, PA)
Application Number:	15/437,534
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,471,067
Patent Claim Types: see list of patent claims	Use; Compound; Dosage form;

Drugs Protected by US Patent 10,471,067

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Baudax	ANJESO	meloxicam	SOLUTION;INTRAVENOUS	210583-001	Feb 20, 2020		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,471,067

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	431131	⤷ Sign Up
Canada	2517679	⤷ Sign Up
Germany	602004021107	⤷ Sign Up
Denmark	3090731	⤷ Sign Up
Denmark	3434261	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.